Psychiatric Medications That Cause Priapism
Antipsychotics and the antidepressant trazodone are the primary psychiatric medications that cause priapism, with the mechanism attributed to alpha-1 adrenergic receptor blockade.
High-Risk Psychiatric Medications
Antipsychotics (Both Typical and Atypical)
The evidence clearly identifies antipsychotics as major culprits for drug-induced priapism 1. Specific agents documented include:
- Risperidone - Multiple case reports demonstrate ischemic priapism, particularly following dose titration or re-initiation 2
- Quetiapine - Can cause recurrent episodes even at standard FDA-approved doses 3
- Aripiprazole - Documented to cause priapism even with a single 10mg dose, despite having the lowest affinity for adrenergic receptors among atypical antipsychotics 4
- Chlorpromazine and other typical antipsychotics - Historically recognized as priapism-inducing agents
Antidepressants
- Trazodone - Well-established association with priapism 5
- Venlafaxine (SNRI) - Rarely implicated but documented to cause low-flow ischemic priapism 6
- SSRIs - Can alter drug plasma concentrations when used as comedication, potentially triggering priapism 5
Other Psychotropic Medications
The guidelines note that "antidepressants and other psychoactive drugs" have been associated with priapism 1, though the evidence is strongest for the medications listed above.
Mechanism and Risk Patterns
The alpha-1 adrenergic receptor blockade is the primary mechanism - these receptors normally maintain penile flaccidity through vasoconstriction. When blocked, uncontrolled arterial inflow can lead to priapism 5, 4.
Common Risk Patterns Identified:
- Drug initiation - Priapism occurring immediately after starting a new psychotropic 5
- Dose changes - Either increases or resumption after a break 2
- Drug interactions - SSRIs as comedication can alter plasma concentrations of other psychotropics 5
- Unpredictable timing - Can occur at nearly any age and any dose 5
Critical Clinical Implications
Patient Counseling
Counsel patients about early warning signs when initiating or restarting antipsychotic therapy - specifically, any prolonged erections should be reported immediately 2. This is particularly important because:
- Priapism can develop after just 3 weeks of therapy 2
- Even single doses can trigger the event 4
- Recurrent episodes can occur within days 3
Emergency Recognition
When evaluating priapism, obtain a detailed medication history focusing on recent psychotropic changes 1. The history should specifically identify:
- Any antipsychotics (current or recently discontinued)
- Trazodone use
- Recent dose adjustments
- Addition of SSRIs or other interacting medications
- Timeline of medication changes relative to priapism onset
Important Caveat
Genetic polymorphisms in alpha-1 adrenergic receptors may explain individual susceptibility 4, meaning some patients are at higher risk regardless of dose or drug selection. This explains why priapism remains unpredictable even with medications having lower receptor affinity.
The evidence consistently shows that while priapism from psychiatric medications is rare, it represents a true urologic emergency requiring immediate intervention to prevent permanent erectile dysfunction 1, 2.